The article “Advanced Tissue Resection in Gastroenterology: Indications, Role, and Techniques” explores the use of advanced tissue resection techniques in gastroenterology. It covers indications for these procedures, their role in patient management, and the various techniques employed. The discussion includes endoscopic mucosal resection (EMR) and endoscopic submucosal dissection (ESD), highlighting their applications, benefits, and challenges. The article emphasizes the importance of these techniques in treating gastrointestinal lesions and improving patient outcomes.
Author: Rutali Thakur
The article delves into the growing trend of “hospital-at-home” care, revealing surprising findings from a recent survey published in The Journal of the American Medical Association. Nearly half of the surveyed consumers are open to receiving medical care at home rather than in traditional hospitals, and only 17% prefer the latter. The study challenges long-held assumptions by showing that preferences aren’t tied to socioeconomic status, medical conditions, or demographics. What makes this concept even more intriguing is the flexibility and technological integration involved. From paramedics performing advanced procedures at home to direct communication with medical teams via tablets, the model…
This article highlights the significant progress in treating inflammatory bowel disease (IBD), emphasizing a shift towards a holistic, patient-centered approach. With the increasing role of advanced practice providers (APPs), there is a greater focus on individualized treatment plans that consider the entire patient journey, not just symptom management. The author discusses the evolution of therapies, particularly the use of biologics like STELARA® (ustekinumab), which have demonstrated long-term efficacy and safety in treating Crohn’s disease and ulcerative colitis. The article also covers the importance of multidisciplinary healthcare teams, comprehensive patient assessments, and the need for tailored treatment approaches that align with…
Cosmo Intelligent Medical Devices (Cosmo IMD), a division of Cosmo Pharmaceuticals, announced FDA 510(k) clearance for the next-generation GI Genius™ hardware. The new hardware, equipped with advanced AI capabilities and the ColonPRO™ software, enhances endoscopy procedures by assisting in polyp detection and standardizing quality metrics. Key features include versatile AI app integration, improved connectivity, energy efficiency, and reliable performance. This development underscores Cosmo IMD’s leadership in AI-enhanced medical technology and commitment to advancing patient care.
Dr. Catherine Bartholomew, a seasoned gastroenterologist, discusses the benefits and opportunities of working as a locum tenens. With her experience transitioning from an academic role to a self-employed locum, Dr. Bartholomew outlines the flexibility and financial benefits locum positions offer. She emphasizes the importance of understanding the role, negotiating with companies, and managing finances as an independent contractor. This guide provides valuable insights for gastroenterologists considering this career path, highlighting the unique advantages and challenges.
Guardant Health’s newly FDA-approved blood test, Shield, offers a non-invasive screening option for colorectal cancer. This liquid biopsy test detects tumor DNA fragments in the blood, providing an alternative to traditional colonoscopies. The approval is expected to boost screening rates and facilitate early detection, especially for those reluctant to undergo more invasive procedures. The Shield test’s development highlights advances in cancer diagnostics and the potential for broader access to early cancer detection.
One GI is leveraging artificial intelligence (AI) to improve patient care and operational efficiency. By integrating AI into their practices, One GI aims to enhance diagnostic accuracy, streamline administrative tasks, and ultimately provide better outcomes for patients. The use of advanced AI technologies allows the organization to stay at the forefront of medical innovation, ensuring high-quality care and optimized practice management.
Researchers have developed a new noninvasive method for diagnosing fatty liver disease, utilizing advanced imaging and machine learning algorithms to detect and quantify liver fat accurately. This technique offers a safer and more accessible alternative to liver biopsies, which are invasive and carry risks. The new method could significantly improve early diagnosis and management of fatty liver disease, benefiting patient outcomes and reducing healthcare costs.
The 2024 MGMA DataDive report reveals key trends in physician compensation, showing shifts in pay structures, productivity metrics, and incentive-based compensation models. The report highlights regional disparities, variations across specialties, and the growing impact of value-based care models on physician earnings. Understanding these trends is essential for healthcare organizations to remain competitive and align their compensation strategies with industry standards.
A recent study highlighted in Forbes reveals that GLP-1 receptor agonists, popular as weight loss drugs, are experiencing declining usage among diabetics. While these drugs effectively aid in weight management, their adoption for diabetes treatment has decreased. This trend raises concerns about the balance between their benefits for weight loss and their role in managing diabetes, prompting further discussion on their optimal use in both contexts.